Amersham Biosciences, General Electric, Affymetrix, Silicon Genetics, Applied Biosystems, Zyomyx | GenomeWeb

Amersham Biosciences this week introduced the Human Whole Genome Bioarray to its CodeLink line of microarrays, becoming the third of the microarray industry’s trio of leaders to field the product, and perhaps marking the last microarray product introduction by the company, which on Thursday is expected to close its acquisition by General Electric. The new CodeLink array targets some some 57,347 transcripts, and approximately 45,674 well-defined and potential genes based on gene content from NCBI UniGene build No. 165 (Jan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.